Induced neuronal reprogramming.
- Authors
- Ang, Cheen Euong; Wernig, Marius
- Year
- 2014
- Journal
- The Journal of comparative neurology
- PMID
- 24771471
- DOI
- 10.1002/cne.23620
- PMCID
- PMC4099045
Cellular differentiation processes during normal embryonic development are guided by extracellular soluble factors such as morphogen gradients and cell contact signals, eventually resulting in induction of specific combinations of lineage-determining transcription factors. The young field of epigenetic reprogramming takes advantage of this knowledge and uses cell fate determination factors to convert one lineage into another such as the conversion of fibroblasts into pluripotent stem cells or neurons. These induced cell fate conversions open up new avenues for studying disease processes, generating cell material for therapeutic intervention such as drug screening and potentially also for cell-based therapies. However, there are still limitations that have to be overcome to fulfill these promises, centering on reprogramming efficiencies, cell identity, and maturation. In this review, we discuss the discovery of induced neuronal reprogramming, ways to improve the conversion process, and finally how to define properly the identity of those converted neuronal cells.
No figures extracted from this document.
| Name | Type |
|---|---|
| 3-dimensional context local | drug |
| 6-hydroxydopamine | drug |
| A10 local | anatomy |
| A8 local | anatomy |
| A9 local | anatomy |
| AADC local | gene |
| Absence of spontaneous synaptic events local | phenotype |
| acetylcholine | drug |
| action potential firing | phenotype |
| adult fibroblasts local | cohort |
| Adult human fibroblast local | cohort |
| adult human fibroblasts local | cohort |
| Adult mouse brain local | anatomy |
| aging | phenotype |
| ALDH1A1 | gene |
| ALS | phenotype |
| ALS patients local | cohort |
| amyotrophic lateral sclerosis | phenotype |
| ANL local | drug |
| Ascl1 | gene |
| Ath5 local | gene |
| authentic brain cell type local | phenotype |
| autism spectrum disorders | phenotype |
| BAM pool local | drug |
| B-cell local | phenotype |
| bFGF | drug |
| BMP | drug |
| Body wall muscle local | phenotype |
| brain | anatomy |
| brain diseases local | phenotype |
| Brn2 | gene |
| Brn3b local | gene |
| CALB1 | gene |
| CEBPA | gene |
| central nervous system | anatomy |
| Chicken beta-actin promoter local | drug |
| cortex | anatomy |
| cortical layer II/III local | anatomy |
| cortical layer IV local | anatomy |
| cortical layer V | anatomy |
| cortical layer VI | anatomy |
| CSPG4 | gene |
| curare local | drug |
| cyclic AMP | drug |
| DCX | gene |
| dibutyryl cyclic AMP local | drug |
| Dlx2 | gene |
| donor cell transcriptional program local | phenotype |
| dopamine | drug |
| Dopamine deficiency local | phenotype |
| dopaminergic neurons | anatomy |
| dorsal tier | anatomy |
| embryonic fibroblasts local | cohort |
| eminentia thalami local | anatomy |
| En1 local | gene |
| epinephrine local | drug |
| ES cell local | phenotype |
| excitatory neuronal cells local | phenotype |
| Fast-fatigable motor neuron local | phenotype |
| Fast-fatigue resistant motor neuron local | phenotype |
| FGF | drug |
| Fibroblast local | phenotype |
| Fibroblast growth factor 8 local | drug |
| Fibroblasts local | cell_type |
| forskolin | drug |
| Foxa2 local | gene |
| FoxA2 local | gene |
| Foxp1 | gene |
| fresh blood cells local | cohort |
| GABA | phenotype |
| Gamma motor neuron local | phenotype |
| GFAP | gene |
| GFP | drug |
| glutamate | drug |
| glutamatergic neurons | phenotype |
| GSK3B | gene |
| hepatic transcripts local | phenotype |
| Hox | gene |
| human blood cells local | cohort |
| Human fetal fibroblast local | cohort |
| Human fibroblast local | cohort |
| human fibroblasts local | phenotype |
| Human induced dopaminergic neurons local | cell_type |
| human postnatal fibroblasts local | cohort |
| iDaN cells local | cell_type |
| iDaN cells local | cohort |
| iDaN cells local | phenotype |
| iN cell local | phenotype |
| iN cell reprogramming local | drug |
| iN cell reprogramming local | phenotype |
| iN cells local | cohort |
| Incomplete assembling of presynaptic compartment local | phenotype |
| induced neuron local | phenotype |
| Induced neuronal cell local | phenotype |
| induced neurons | phenotype |
| Induced pluripotent stem cell local | phenotype |
| induced retinal ganglion-like cells local | phenotype |
| iPS cell local | phenotype |
| iPS cells | cohort |
| iPS cell technology local | drug |
| Isl1 | gene |
| Kcnj6 | gene |
| Klf4 | gene |
| Lateral division of Lateral motor column local | anatomy |
| Lateral motor column local | anatomy |
| LHX3 | gene |
| Lim1 local | gene |
| Lim3 local | gene |
| Limb muscle local | phenotype |
| linear poly amido amine local | drug |
| Lmx1a local | gene |
| LMX1A local | gene |
| Macrophage local | phenotype |
| MAP2 | gene |
| Mapt | gene |
| Medial division of Lateral motor column local | anatomy |
| Medial motor column local | anatomy |
| MEFs local | cohort |
| mesencephalon | anatomy |
| mice | cohort |
| midbrain | anatomy |
| midbrain dopaminergic neurons local | phenotype |
| Midbrain-type neuron local | phenotype |
| miR-124 | drug |
| miR-9 | drug |
| MNX1 local | gene |
| Moloney Murine Leukemia Virus retroviral vector local | drug |
| motor cortex | anatomy |
| mouse brain | anatomy |
| mouse cortex | anatomy |
| Mouse fibroblast local | cohort |
| Mouse iDaN cells local | cell_type |
| Muscle cell local | phenotype |
| Myc | gene |
| MYOD1 local | gene |
| Myt1l | gene |
| MZ | anatomy |
| neonatal fibroblasts local | cohort |
| Neonatal mouse brain local | anatomy |
| neuroblasts | anatomy |
| NEUROD1 | gene |
| NEUROD2 | gene |
| NEUROG2 | gene |
| neurogenesis | phenotype |
| Neuroligin 4 local | gene |
| neuronal purity local | phenotype |
| neuronal reprogramming local | phenotype |
| neuronal subtype local | phenotype |
| neuronal yield local | phenotype |
| neurons | phenotype |
| Ngn2 | gene |
| norepinephrine | drug |
| NR4A2 | gene |
| Oct4 | gene |
| olfactory bulb | anatomy |
| Olig2 | gene |
| Olig2-VP16 local | variant |
| oxygen | drug |
| P19 cells local | cohort |
| Parkinson's disease | phenotype |
| Parkinsonβs disease | phenotype |
| patient-derived cells local | drug |
| Pax6 | gene |
| peripheral nervous system | anatomy |
| Pitx3 local | gene |
| PITX3 local | gene |
| Pitx3-GFP knock-in mice local | cohort |
| POU3F2 | gene |
| preplate local | anatomy |
| Presynaptic incompetence local | phenotype |
| primary visual cortex | anatomy |
| PRPH | gene |
| PTB local | gene |
| RBFOX3 | gene |
| retrorubral area local | anatomy |
| RIEG/PITX homeobox family local | gene |
| RPF-1 local | gene |
| Self-inactivating retroviral vector local | drug |
| skin-derived fibroblasts local | cohort |
| Slc17a7 | gene |
| SLC18A2 | gene |
| SLC6A3 | gene |
| Slow-twitch alpha motor neuron local | phenotype |
| Sod1 | gene |
| SOD1 G93A local | variant |
| somatosensory cortex | anatomy |
| Sonic hedgehog | drug |
| Sox2 | gene |
| specific synaptic phenotype local | phenotype |
| spinal motor neurons | anatomy |
| stab wound lesion local | anatomy |
| striatum | anatomy |
| substantia nigra | anatomy |
| subventricular zone | anatomy |
| synapse formation | phenotype |
| synaptic phenotype local | phenotype |
| Tbr1 | gene |
| TGFΞ² | drug |
| Th | gene |
| Thy1.2 local | gene |
| TUBB3 | gene |
| Tuj1-positive cells local | phenotype |
| ventral midbrain | anatomy |
| ventral tegmental area | anatomy |
| ventral tier | anatomy |
| ventricular zone | anatomy |
| VMAT local | gene |
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | 2023 | 36207584 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases. | Qin R et al. | β | 2026 | β |
| Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion. | Wang Y et al. | β | 2025 | β |
| Direct transdifferentiation of tumorigenic melanoma cells induces tumor cell reversion | Utikal J et al. | β | 2024 | β |
| Generation of human excitatory forebrain neurons by cooperative binding of proneural NGN2 and homeobox factor EMX1. | Ang CE et al. | β | 2024 | β |
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | Popova D et al. | β | 2023 | β |
| Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation. | Woods LM et al. | β | 2022 | β |
| Combinatorial Atoh1 and Gfi1 induction enhances hair cell regeneration in the adult cochlea. | Lee S et al. | β | 2020 | β |
| Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions. | Assetta B et al. | β | 2020 | β |
| Attenuation of PRRX2 and HEY2 enables efficient conversion of adult human skin fibroblasts to neurons. | Li H et al. | β | 2019 | β |
| Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications. | Essayan-Perez S et al. | β | 2019 | β |
| Nanomaterial-Based Approaches for Neural Regeneration. | Teleanu RI et al. | β | 2019 | β |
| The novel lncRNA <i>lnc-NR2F1</i> is pro-neurogenic and mutated in human neurodevelopmental disorders. | Ang CE et al. | β | 2019 | β |
| Myt1l induced direct reprogramming of pericytes into cholinergic neurons. | Liang XG et al. | β | 2018 | β |
| Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. | Sonntag KC et al. | β | 2018 | β |
| Transdifferentiation of human adult peripheral blood T cells into neurons. | Tanabe K et al. | β | 2018 | β |
| Direct Conversion of Human Fibroblasts into Neural Progenitors Using Transcription Factors Enriched in Human ESC-Derived Neural Progenitors. | Hou PS et al. | β | 2017 | β |
| KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis. | Lin H et al. | β | 2017 | β |
| Bioinformatic and Genomic Analyses of Cellular Reprogramming and Direct Lineage Conversion. | Kareta MS | β | 2016 | β |
| Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders. | Panchision DM | β | 2016 | β |
| InΒ Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells. | Li H et al. | β | 2016 | β |
| Mechanisms and Developmental Roles of Promoter-proximal Pausing of RNA Polymerase II. | Robinson C et al. | β | 2016 | β |
| Retinal regeneration in birds and mice. | Wilken MS et al. | β | 2016 | β |
| Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to Neurodegeneration. | Vermunt MW et al. | β | 2016 | β |
| Advances in reprogramming-based study of neurologic disorders. | Nityanandam A et al. | β | 2015 | β |
| Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo. | Liu Y et al. | β | 2015 | β |
| Direct conversion of mouse fibroblasts to GABAergic neurons with combined medium without the introduction of transcription factors or miRNAs. | Xu H et al. | β | 2015 | β |
| Elevated in vivo levels of a single transcription factor directly convert satellite glia into oligodendrocyte-like cells. | Weider M et al. | β | 2015 | β |
| [Inducing brain regeneration from within: in vivo reprogramming of endogenous somatic cells into neurons]. | Heinrich C et al. | β | 2015 | β |
| Moving stem cells to the clinic: potential and limitations for brain repair. | Steinbeck JA et al. | β | 2015 | β |
| Multi-site phospho-regulation of proneural transcription factors controls proliferation versus differentiation in development and reprogramming. | Philpott A | β | 2015 | β |
| Human stem cell models of dementia. | Livesey FJ | β | 2014 | β |